Lianxin Liu

机构：University of Science and Technology of China, Harbin Medical University, Anhui Provincial Hospital, First Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-9000-4344

发表论文 90 篇 · 总被引 3487 次 · h-index 33

代表论文

• DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation (2021 · Advanced Science · 被引 85)
• The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications (2022 · Frontiers in Immunology · 被引 73)
• Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements (2022 · Liver Cancer · 被引 70)
• LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11‐dependent repression of CDKN2A (2023 · Clinical and Translational Medicine · 被引 46)
• <p>Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma</p> (2020 · OncoTargets and Therapy · 被引 45)
• MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation (2022 · Journal of Experimental & Clinical Cancer Research · 被引 32)